Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 678 of 5804
-
Experimental drug HDP-101 targets Hard-to-Treat myeloma
Disease control Recruiting nowThis study will assess the safety, tolerability, pharmacokinetics (PK) and the therapeutic potential of HDP-101 in patients with plasma cell disorders including multiple myeloma.
Phase: PHASE1, PHASE2 • Sponsor: Heidelberg Pharma AG • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Can a better diet during malnutrition recovery rewire a Child's brain?
Disease control CompletedThe study explores the impact of malnutrition at enrollment on executive function (EF) and emotional regulation (ER) in malnourished 1-year-old children and whether specially designed brain directed therapeutic feeds improve EF/ER outcomes at three years of age. The study will de…
Phase: NA • Sponsor: Boston Children's Hospital • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Immune booster after standard therapy may stall nasopharyngeal cancer
Disease control Recruiting nowThe clinical efficacy of nivolumab for locally advanced nasopharyngeal carcinoma patients with residual disease after standard chemoradiotherapy is not known. In this study, we aim to investigate the role of nivolumab in locally advanced NPC after chemoradiotherapy the safety pro…
Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New combo aims to boost immune attack on liver tumors after radiation
Disease control Recruiting nowThis phase II trial studies how well standard of care hypofractionated radiation therapy followed by durvalumab with or without tremelimumab works in treating patients with hepatocellular cancer (liver cancer) that has spread to other places in the body (advanced) and that is gro…
Phase: PHASE2 • Sponsor: Mary Feng, MD • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New combo therapy aims to boost leukemia remission
Disease control Recruiting nowThis phase I/II trial finds the best dose, side effects and how well giving venetoclax in combination with cladribine, cytarabine, granulocyte colony-stimulating factor, and mitoxantrone (CLAG-M) in treating patients with acute myeloid leukemia and high-grade myeloid neoplasms. V…
Phase: PHASE1, PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Heart device trial aims to boost function in patients with preserved pumping ability
Disease control Recruiting nowThe AIM HIGHer Clinical Trial will evaluate the safety and efficacy of Cardiac Contractility Modulation (CCM) therapy in patients with heart failure with LVEF ≥40% and ≤70%.
Phase: NA • Sponsor: Impulse Dynamics • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Promising drug aims to stop Flare-Ups in rare brain disease
Disease control OngoingThe purpose of the study is to evalute the efficacy, safety and tolerability of rozanolixizumab for treatment of adult participants with myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD).
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Housing instead of handcuffs: new trial for homeless with mental illness
Disease control OngoingPeople who are homeless with severe psychiatric disorders have to negotiate discontinuous mental health care pathways including high use of emergency departement and enforced hospitalisation, poor access to ambulatory care, poor access to common rights services and a greater risk…
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New shingles vaccine CRV-101 takes on shingrix in Head-to-Head trial
⭐️ VACCINE ⭐️ OngoingThe purpose of this study is to assess the safety and immunogenicity of amezosvatein (CRV-101), an investigational vaccine compared to Shingrix® for the prevention of herpes zoster in adults aged 50 years and older
Phase: PHASE2 • Sponsor: Curevo Inc • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 07:53 UTC
-
Could a simple vacuum dressing slash infection rates in sarcoma surgery?
Disease control Recruiting nowProject Summary - Aggressive soft tissue cancers are commonly treated with radiation followed by surgery. These wounds have a very high rate of wound complications and infection (30%), resulting in more surgeries, longer hospital stays and complex nursing care. Previous research …
Phase: NA • Sponsor: Dr. J. Werier • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Your digital twin could help beat diabetes
Disease control OngoingThis is a randomized study comparing outcomes of patients diagnosed with Type 2 Diabetes (T2D) who are enrolled into the Twin Health Precision Treatment (TPT) system versus usual care. The study will last for a year with a 1 year optional extension for the TPT arm patients to con…
Phase: NA • Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Jun 26, 2026 17:33 UTC
-
Lymphoma patients may get a simpler shot option
Disease control OngoingThis study will evaluate the efficacy, safety, and pharmacokinetics of mosunetuzumab subcutaneous (SC) formulation in participants with selected B-cell malignancies (types of non-Hodgkin's lymphoma \[NHL\]).
Phase: PHASE2 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New trial tests drug combo to keep ovarian cancer at bay
Disease control Recruiting nowRandomized, open label, phase II multicenter study to assess the efficacy niraparib versus niraparib +bevacizumab maintenance in patients with newly diagnosed stage IIIA/B/C high-grade epithelial ovarian cancer with no residual disease after frontline surgery and treatment by adj…
Phase: PHASE2 • Sponsor: ARCAGY/ GINECO GROUP • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New combo aims to stop leukemia return after transplant
Disease control Recruiting nowThe goal of this clinical research study is to learn if azacitidine combined with Chidamide will help to control the disease in patients with high-risk AML after an allogeneic stem cell transplant. The safety of this combination will also be studied.
Phase: PHASE1, PHASE2 • Sponsor: Zhujiang Hospital • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
AI could uncover hidden lung disease in routine chest X-Rays
Diagnosis CompletedThe goal of this observational study is to learn how well an artificial intelligence (AI)-based chest X-ray analysis software can incidentally detect interstitial lung disease (ILD), which appears as interstitial opacity, on chest X-rays taken for other reasons, and whether these…
Sponsor: Chung-Ang University Hospital • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
Weekly chemo may be gentler for head and neck cancer patients
Disease control TerminatedThis phase II/III trial compares whether cisplatin given weekly with radiation therapy is better tolerated than cisplatin given every three weeks with radiation therapy for the treatment of head and neck cancer that has spread to other places in the body (advanced). The second pa…
Phase: PHASE2, PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Gene therapy for rare blood disease shows promise in Long-Term Follow-Up
Disease control ENROLLING_BY_INVITATIONLong-Term Follow-up: Phase I/II clinical study to evaluate the safety and efficacy of the infusion of RP-L102
Sponsor: Rocket Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New drug combo shows promise in shrinking breast tumors before surgery
Disease control OngoingThis study will test any good and bad effects of combining the study drugs pembrolizumab and olaparib, given before the standard surgical procedure, to treat TNBC or HR+ HER2- breast cancers. The study drugs could shrink cancer, but they could also cause side effects. The study r…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New implant zaps nerves to stop bladder leaks
Disease control CompletedThe purpose of this prospective, multicenter study is to assess the safety and efficacy of tibial neuromodulation using the Medtronic Tibial Neuromodulation (TNM) system.
Phase: NA • Sponsor: MedtronicNeuro • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New drug cocktail shows promise in shrinking HER2+ stomach tumors before surgery
Disease control OngoingThis study is an open-label, single-arm, multicenter, Phase 2 study to evaluate the efficacy and safety of neoadjuvant chemotherapy with T-DXd monotherapy in patients with HER2-positive gastric cancer. In the combination cohort, the efficacy and safety of neoadjuvant chemotherap…
Phase: PHASE2 • Sponsor: National Cancer Center Hospital East • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC